Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
about
Risk and Surveillance of Cancers in Primary Biliary Tract DiseaseThe landscape of targeted therapies for cholangiocarcinoma: current status and emerging targetsEpithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancerAberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like propertiesJagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans.Regulated intramembrane proteolysis of the TGFβ type I receptor conveys oncogenic signals.Molecular mechanism of cholangiocarcinoma carcinogenesis.Emerging roles of Notch signaling in liver disease.The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.The potential role of liver stem cells in initiation of primary liver cancer.Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axisRole of the Notch signaling in cholangiocarcinoma.The cholangiocyte primary cilium in health and disease.Notch Signaling in Development, Tissue Homeostasis, and Disease.Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma.ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.Therapie des metastasierten Cholangiokarzinoms
P2860
Q26740434-A72F6C71-83C3-44CF-A7BB-5FC75CC83C73Q26751224-DBB375DE-A73D-4A09-BCF1-6C0E5AE46FDCQ26771988-271AF148-079F-4734-924F-A2F87C84723BQ33728068-FF0856DB-4A75-4AF6-BB11-D4866456D093Q36184732-C66FC568-50F6-48B3-96C6-3DBF90B6CA91Q37525776-E191A206-833A-4F18-8433-63896B194DE5Q38193549-C8E8082A-BDD4-4D82-AAFB-B767C4BC6B3CQ38217475-F53F91CE-598D-4D0C-B62E-BB1B5E42FBE4Q38220343-552CCB79-32A3-4E14-9467-CF417709D058Q38654010-361403CE-567B-43BC-B88E-72B9066B1AF3Q38823884-F1DD2295-67E6-4CB8-9BFC-ECB703257AF7Q39176356-F9869AD8-D7BE-4002-889D-8F51F6768B3DQ39192384-E93325A1-00A3-4767-B7F5-610ED86C456CQ39381392-BD15F3AB-12D3-4991-822A-F3C2900B5C8AQ46795621-2A4355EE-90CD-4E90-8D16-CDC0D1E9CE39Q47550861-8587C43A-8032-4412-B624-38261460B51DQ47603972-7959EE56-3AC6-4694-9F33-74B682B63F03Q52729640-3B56C7AF-9605-47AB-A964-F2427111E7A2Q55032209-DC9A7AC5-CC77-4A5B-9CF3-256AC229E359Q55656403-81CE1F4B-F579-4F37-B351-BFE123638875Q57074642-0244050A-C3C5-4A83-833E-BE3DEB04C6A6
P2860
Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Activation of Notch signaling ...... y inactivation of p53 in vivo.
@ast
Activation of Notch signaling ...... y inactivation of p53 in vivo.
@en
type
label
Activation of Notch signaling ...... y inactivation of p53 in vivo.
@ast
Activation of Notch signaling ...... y inactivation of p53 in vivo.
@en
prefLabel
Activation of Notch signaling ...... y inactivation of p53 in vivo.
@ast
Activation of Notch signaling ...... y inactivation of p53 in vivo.
@en
P2093
P2860
P1433
P1476
Activation of Notch signaling ...... y inactivation of p53 in vivo.
@en
P2093
Ludwig Wilkens
Mona El Khatib
Nisar P Malek
Przemyslaw Bozko
Ruben R Plentz
Vindhya Palagani
P2860
P304
P356
10.1371/JOURNAL.PONE.0077433
P407
P577
2013-10-30T00:00:00Z